Search results
A company insider recently sold 6,095 shares of Bluebird bio Inc [BLUE]. Should You also Consider to...
Knox Daily· 6 hours agoBluebird bio Inc’s filing revealed that its President and CEO Obenshain Andrew unloaded Company’s shares for reported $9311.0 on Mar 04 ’24. In the deal ...
Bluebird bio Inc: Is BLUE Stock Worth Buying? – Stocks Register
Stocks Register· 23 hours agoThe trading price of Bluebird bio Inc (NASDAQ:BLUE) closed lower on Monday, May 13, closing at $1.02, -3.77% lower than its previous close. In examining ...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel...
WKRN Nashville· 9 hours agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and ...
Earnings call: Bluebird bio reports Q1 2024 results, anticipates growth By Investing.com
Investing.com· 5 days agoBluebird bio Inc. (BLUE) has announced its first-quarter 2024 financial results, highlighting the...
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agobluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024 bluebird bio, Inc....
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
GuruFocus.com via Yahoo Finance· 4 days agoOn May 9, 2024, bluebird bio Inc (NASDAQ:BLUE), a leader in gene therapy innovation, released its first quarter financial results through an 8-K filing.
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi &...
WFRV 5 Green Bay· 2 days agoLevi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of ...
bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28,...
Benzinga· 1 day agoInvestors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc. ("bluebird" or the
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
WKRN Nashville· 5 days agoNEW YORK, May 10, 2024 Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against bluebird bio, Inc. ("Blue ...
bluebird bio (BLUE) Scheduled to Post Quarterly Earnings on Thursday
ETF DAILY NEWS· 7 days agoAnalysts expect bluebird bio to post earnings of ($0.47) per share for the quarter. Parties that are interested in registering for the company’s conference ...